These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 38298913)

  • 21. The simple perfection of quantum correlation in human vision.
    Bouman MA
    Prog Neurobiol; 2006 Jan; 78(1):38-60. PubMed ID: 16377059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is adding a new class of cones to the retina sufficient to cure color-blindness?
    Cornelissen FW; Brenner E
    J Vis; 2015; 15(13):22. PubMed ID: 26418498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Physiology and pathology of visual information processing].
    Kitahara K
    Nippon Ganka Gakkai Zasshi; 2007 Mar; 111(3):160-91; discussion 192. PubMed ID: 17402561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetics of color vision deficiencies.
    Deeb SS; Kohl S
    Dev Ophthalmol; 2003; 37():170-87. PubMed ID: 12876837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The construction of genetics teaching resources related to colour blindness and their application in genetics teaching.
    Mao CX
    Yi Chuan; 2024 Apr; 46(4):346-354. PubMed ID: 38632096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The dyschromatopsia of optic neuritis is determined in part by the foveal/perifoveal distribution of visual field damage.
    Silverman SE; Hart WM; Gordon MO; Kilo C
    Invest Ophthalmol Vis Sci; 1990 Sep; 31(9):1895-902. PubMed ID: 2211035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential diagnosis of typical and atypical congenital achromatopsia. Analysis of a progressive foveal dystrophy and a nonprogressive oligo-cone trichromasy (general cone dysfunction without achromatopsia), both of which at first had been diagnosed as achromatopsia.
    Neuhann T; Krastel H; Jaeger W
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1978 Dec; 209(1):19-28. PubMed ID: 311163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene Therapy for Achromatopsia.
    Baxter MF; Borchert GA
    Int J Mol Sci; 2024 Sep; 25(17):. PubMed ID: 39273686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis and Treatment Options for Achromatopsia: A Review of the Literature.
    Pascual-Camps I; Barranco-Gonzalez H; Aviñó-Martínez J; Silva E; Harto-Castaño M
    J Pediatr Ophthalmol Strabismus; 2018 Mar; 55(2):85-92. PubMed ID: 29257187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AAV-mediated cone rescue in a naturally occurring mouse model of CNGA3-achromatopsia.
    Pang JJ; Deng WT; Dai X; Lei B; Everhart D; Umino Y; Li J; Zhang K; Mao S; Boye SL; Liu L; Chiodo VA; Liu X; Shi W; Tao Y; Chang B; Hauswirth WW
    PLoS One; 2012; 7(4):e35250. PubMed ID: 22509403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in ocular findings in two siblings: one with complete and other with incomplete achromatopsia.
    Ueno S; Nakanishi A; Sayo A; Kominami T; Ito Y; Hayashi T; Tsunoda K; Iwata T; Terasaki H
    Doc Ophthalmol; 2017 Apr; 134(2):141-147. PubMed ID: 28197754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential distributions of red-green and blue-yellow cone opponency across the visual field.
    Mullen KT; Kingdom FA
    Vis Neurosci; 2002; 19(1):109-18. PubMed ID: 12180855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced Discrimination in the Tritanopic Confusion Line for Congenital Color Deficiency Adults.
    Costa MF; Goulart PR; Barboni MT; Ventura DF
    Front Psychol; 2016; 7():429. PubMed ID: 27065909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular genetics of color-vision deficiencies.
    Deeb SS
    Vis Neurosci; 2004; 21(3):191-6. PubMed ID: 15518188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Achromatopsia: Genetics and Gene Therapy.
    Michalakis S; Gerhardt M; Rudolph G; Priglinger S; Priglinger C
    Mol Diagn Ther; 2022 Jan; 26(1):51-59. PubMed ID: 34860352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of acute high intraocular pressure on red-green and blue-yellow cortical color responses in non-human primates.
    Li M; Chen X; Yuan N; Lu Y; Liu Y; Gong H; Qian L; Andolina IM; Wu J; Zhang S; McLoughlin N; Sun X; Wang W
    Neuroimage Clin; 2022; 35():103092. PubMed ID: 35753237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional photoreceptor loss revealed with adaptive optics: an alternate cause of color blindness.
    Carroll J; Neitz M; Hofer H; Neitz J; Williams DR
    Proc Natl Acad Sci U S A; 2004 Jun; 101(22):8461-6. PubMed ID: 15148406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene Augmentation Therapy Restores Retinal Function and Visual Behavior in a Sheep Model of CNGA3 Achromatopsia.
    Banin E; Gootwine E; Obolensky A; Ezra-Elia R; Ejzenberg A; Zelinger L; Honig H; Rosov A; Yamin E; Sharon D; Averbukh E; Hauswirth WW; Ofri R
    Mol Ther; 2015 Sep; 23(9):1423-33. PubMed ID: 26087757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Statistical and molecular analyses of evolutionary significance of red-green color vision and color blindness in vertebrates.
    Yokoyama S; Takenaka N
    Mol Biol Evol; 2005 Apr; 22(4):968-75. PubMed ID: 15647522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medical legal validity of the use of the anomaloscope in the dyschromatopsia of aspiring civil and military aircraft pilots.
    Salducci M; Deandri A
    Rom J Ophthalmol; 2020; 64(2):153-157. PubMed ID: 32685781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.